Literature DB >> 8903474

Expression pattern of S100 calcium-binding proteins in human tumors.

E C Ilg1, B W Schäfer, C W Heizmann.   

Abstract

The S100 Ca(2+)-binding proteins recently became of major interest because of their differential expression in neoplastic tissues, their involvement in metastatic processes, and the clustered organization of at least 10 S100 genes on human chromosome 1q21, a region frequently rearranged in several tumors. As a first attempt towards a specific and differentiated immunohistochemical classification of human tumors, we produced, purified and characterized a number of human recombinant S100 proteins and raised specific polyclonal antibodies. Their distinct cellular and intracellular localization was examined by immunohistochemical methods in normal and cancerogenic human tissues and cell lines. S100A1 and S100A2 can be detected in a few normal tissues only, whereas S100A4, S100A6, and S100B are expressed at higher levels in cancer tissues. In the future, these S100 antibodies will potentially be of great value in cancer diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903474     DOI: 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  32 in total

1.  Diagnosis of Creutzfeldt-Jakob disease. Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jakob disease is not justified.

Authors:  M Zeidler; R Knight; G Stewart; J W Ironside; R G Will; A J Green; M Pocchiari
Journal:  BMJ       Date:  1999-02-20

2.  Protein S100A4: too long overlooked by pathologists?

Authors:  Luca Mazzucchelli
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death.

Authors:  Eiichi Makino; Masakiyo Sakaguchi; Keiji Iwatsuki; Nam-ho Huh
Journal:  J Mol Med (Berl)       Date:  2004-07-06       Impact factor: 4.599

4.  Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes.

Authors:  Eivind Valen Egeland; Kjetil Boye; Solveig J Pettersen; Mads H Haugen; Tove Øyjord; Lene Malerød; Kjersti Flatmark; Gunhild M Mælandsmo
Journal:  Clin Exp Metastasis       Date:  2015-09-09       Impact factor: 5.150

5.  Psoriasin (S100A7) expression and invasive breast cancer.

Authors:  S Al-Haddad; Z Zhang; E Leygue; L Snell; A Huang; Y Niu; T Hiller-Hitchcock; K Hole; L C Murphy; P H Watson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 6.  S100B as a marker for brain damage and blood-brain barrier disruption following exercise.

Authors:  Serene X T Koh; Jason K W Lee
Journal:  Sports Med       Date:  2014-03       Impact factor: 11.136

7.  Morphological characterization of pecteneal hyalocytes in the developing quail retina.

Authors:  Cristina Llombart; Víctor Nacher; David Ramos; Mariana Luppo; Ana Carretero; Marc Navarro; Verònica Melgarejo; Clara Armengol; Alfonso Rodríguez-Baeza; Luisa Mendes-Jorge; Jesús Ruberte
Journal:  J Anat       Date:  2009-06-29       Impact factor: 2.610

8.  Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues.

Authors:  Guiyu Wang; Xishan Wang; Shuhuai Wang; Hongtao Song; Haiming Sun; Weiguang Yuan; Bo Cao; Jing Bai; Songbin Fu
Journal:  Int J Colorectal Dis       Date:  2008-03-14       Impact factor: 2.571

9.  Immunohistochemical analysis of brain lesions using S100B and glial fibrillary acidic protein antibodies in arundic acid- (ONO-2506) treated stroke-prone spontaneously hypertensive rats.

Authors:  Hideaki Higashino; Atsuko Niwa; Takao Satou; Yoshio Ohta; Shigeo Hashimoto; Masaki Tabuchi; Kana Ooshima
Journal:  J Neural Transm (Vienna)       Date:  2009-08-06       Impact factor: 3.575

10.  Calcium-binding S100 protein expression in pterygium.

Authors:  Andri K Riau; Tina T Wong; Roger W Beuerman; Louis Tong
Journal:  Mol Vis       Date:  2009-02-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.